Design, Synthesis, and In-silico Evaluation of Benzyl oxybenzoate Derivatives as Dual HDAC Inhibitors for Cancer and CNS Disorders. (2026). Al Mustansiriyah Journal of Pharmaceutical Sciences, 25(5), 917-930. https://doi.org/10.32947/ajps.v25i5.1307